brentuximab vedotin

brentuximab vedotin (ADCETRIS) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: injection. Current US regulatory status: approved.

ADCETRIS is a marketed brand name for brentuximab vedotin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

brentuximab vedotin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.